|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,599 GBX | +0.98% |
|
-2.71% | +10.26% |
| Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
| Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
Aug 2 (Reuters) - GlaxoSmithKline PLC:
* GSK - FILES FOR LICENSURE OF MMR VACCINE IN U.S.
* GSK - SUBMITTED A BLA TO U.S. FDA FOR PRIORIX, SEEKING APPROVAL FOR USE IN ACTIVE IMMUNIZATION AGAINST INFECTION BY MEASLES, MUMPS AND RUBELLA (MMR) Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +10.26% | 80.65B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
GSK PLC 
